...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - Jan 7, 2016 - Details

jbuffett62

I'm anxious to read the published company version - as Masila stated:

First, some caveats.Please understand that I’ve done my best to transcribe what I heard, but there’s always room for misinterpretation or forgetting something.So don’t go saying “Don said so and so at the AGM” unless you heard it yourself… I can’t guarantee I got everything right.

Based on my read of Masila's notes I agree with you - something is in the wind -

Chicagoest

Share
New Message
Please login to post a reply